Insider Trading activities at Genomic Health Inc (GHDX) , Part 3

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genomic Health Inc (GHDX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genomic Health Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1131324.

Total stock buying since 2014: $2,701,600.
Total stock sales since 2014: $524,742,527.
Total stock option exercises since 2014: $54,237,607.


 1   2   3 
19 insiders reported insider trading activities at Genomic Health Inc (GHDX):
Insider trading activities of 14159, L.p.
Insider trading activities of Graham Ginger L
Insider trading activities of Baker/tisch Investments, Lp
Insider trading activities of Baker Bros. Investments, L.p.
Insider trading activities of Baker Bros. Investments Ii, L.p.
Insider trading activities of Vaughn James J
Insider trading activities of Livingston Randall S
Insider trading activities of Popovits Kimberly J
Insider trading activities of Baker Bros. Advisors (gp) Llc
Insider trading activities of Cohen Fred E
Insider trading activities of Schorno Dean L
Insider trading activities of Shak Steven
Insider trading activities of Exact Sciences Corp
Insider trading activities of Febbo Phillip G.
Insider trading activities of Radford Jason W.
Insider trading activities of Pla Frederic
Insider trading activities of Mceachron Kim
Insider trading activities of Cole G Bradley
Insider trading activities of Leber Laura

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Genomic Health Inc (GHDX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2019 37,643,330 $0 4,255,395 $302,840,723 1,177,273 $31,943,202
2018 0 $0 2,775,805 $206,377,815 561,292 $12,545,100
2017 0 $0 218,781 $6,847,246 255,541 $4,916,282
2016 100,000 $2,701,600 148,242 $4,293,432 181,950 $3,190,607
2015 0 $0 65,864 $1,910,548 65,864 $879,494
2014 0 $0 85,321 $2,472,763 85,321 $762,922


Table 3. Detailed insider trading at Genomic Health Inc (GHDX) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-05-31 Baker/tisch Investments, Lp (Director) Option Ex 49,500 18.13 897,435
2017-05-23 Shak Steven (Chief Scientific Officer) Sale 5,000 29.40 146,980
2017-05-23 Shak Steven (Chief Scientific Officer) Option Ex 5,000 23.31 116,550
2017-05-19 Cohen Fred E (Director) Sale 8,250 29.55 243,746
2017-05-19 Cohen Fred E (Director) Option Ex 8,250 14.37 118,552
2017-05-18 Cohen Fred E (Director) Sale 16,500 29.88 493,036
2017-05-18 Cohen Fred E (Director) Option Ex 16,500 18.05 297,742
2017-05-16 Cohen Fred E (Director) Sale 8,250 30.68 253,101
2017-05-16 Cohen Fred E (Director) Option Ex 8,250 18.13 149,572
2017-05-03 Popovits Kimberly J (President and CEO) Sale 5,000 31.78 158,920
2017-05-03 Popovits Kimberly J (President and CEO) Option Ex 5,000 17.33 86,649
2017-04-24 Shak Steven (Chief Scientific Officer) Sale 5,000 31.46 157,325
2017-04-24 Shak Steven (Chief Scientific Officer) Option Ex 5,000 23.31 116,550
2017-04-03 Popovits Kimberly J (President and CEO) Sale 5,000 31.30 156,505
2017-04-03 Popovits Kimberly J (President and CEO) Option Ex 5,000 20.32 101,600
2017-03-23 Shak Steven (Chief Scientific Officer) Sale 5,000 31.26 156,295
2017-03-23 Shak Steven (Chief Scientific Officer) Option Ex 5,000 23.31 116,550
2017-03-20 Leber Laura (Chief Communication Officer) Sale 3,072 31.88 97,941
2017-03-08 Cole G Bradley (COO) Sale 5,710 30.70 175,319
2017-03-08 Cole G Bradley (COO) Option Ex 5,710 23.31 133,100
2017-03-06 Popovits Kimberly J (President and CEO) Sale 290 31.08 9,014
2017-03-06 Popovits Kimberly J (President and CEO) Option Ex 290 23.31 6,759
2017-03-03 Popovits Kimberly J (President and CEO) Sale 4,710 31.09 146,438
2017-03-03 Popovits Kimberly J (President and CEO) Option Ex 4,710 23.31 109,790
2017-02-23 Shak Steven (Chief Scientific Officer) Sale 5,000 29.36 146,815
2017-02-23 Shak Steven (Chief Scientific Officer) Option Ex 5,000 23.31 116,550
2017-02-16 Febbo Phillip G. (Chief Medical Officer) Sale 2,495 30.09 75,087
2017-02-15 Cole G Bradley (COO) Sale 5,000 29.00 145,000
2017-02-15 Cole G Bradley (COO) Option Ex 5,000 23.31 116,550
2017-01-23 Shak Steven (Chief Scientific Officer) Sale 5,000 27.28 136,385
2017-01-23 Shak Steven (Chief Scientific Officer) Option Ex 5,000 23.31 116,550
2017-01-10 Cole G Bradley (COO) Sale 5,000 29.22 146,085
2017-01-10 Cole G Bradley (COO) Option Ex 5,000 23.31 116,550
2016-12-06 Cole G Bradley (COO) Sale 5,000 30.61 153,030
2016-12-06 Cole G Bradley (COO) Option Ex 5,000 23.31 116,550
2016-12-05 Popovits Kimberly J (President and CEO) Sale 15,000 30.02 450,300
2016-12-05 Popovits Kimberly J (President and CEO) Option Ex 15,000 23.31 349,650
2016-11-21 Leber Laura (Chief Communication Officer) Sale 7,068 31.73 224,267
2016-11-21 Leber Laura (Chief Communication Officer) Option Ex 3,600 17.41 62,676
2016-11-10 Shak Steven (Chief Scientific Officer) Sale 5,000 31.89 159,445
2016-11-10 Shak Steven (Chief Scientific Officer) Option Ex 5,000 18.89 94,450
2016-11-08 Cole G Bradley (COO) Sale 5,000 29.68 148,420
2016-11-08 Cole G Bradley (COO) Option Ex 5,000 23.31 116,550
2016-11-03 Popovits Kimberly J (President and CEO) Sale 5,313 28.88 153,423
2016-11-03 Popovits Kimberly J (President and CEO) Option Ex 5,313 18.89 100,362
2016-10-11 Shak Steven (Chief Scientific Officer) Sale 5,000 30.39 151,925
2016-10-11 Shak Steven (Chief Scientific Officer) Option Ex 5,000 18.89 94,450
2016-10-10 Cole G Bradley (COO) Sale 8,290 30.59 253,599
2016-10-10 Cole G Bradley (COO) Option Ex 8,290 21.10 174,919
2016-10-06 Vaughn James J (Chief Commercial Officer) Sale 3,000 29.68 89,043
2016-09-13 Shak Steven (Chief Scientific Officer) Sale 5,000 26.83 134,155
2016-09-13 Shak Steven (Chief Scientific Officer) Option Ex 5,000 18.89 94,450
2016-09-06 Cole G Bradley (COO) Sale 4,000 27.41 109,636
2016-09-06 Cole G Bradley (COO) Option Ex 4,000 18.89 75,560
2016-08-23 Shak Steven (Chief Scientific Officer) Sale 5,000 27.24 136,215
2016-08-23 Shak Steven (Chief Scientific Officer) Option Ex 5,000 18.89 94,450
2016-08-15 Baker Bros. Investments, L.p. (Director) Buy 100,000 27.02 2,701,600
2016-08-11 Cole G Bradley (COO) Sale 5,000 28.88 144,375
2016-08-11 Cole G Bradley (COO) Option Ex 5,000 18.89 94,450
2016-08-08 Vaughn James J (Chief Commercial Officer) Sale 3,000 28.74 86,223
2016-07-19 Shak Steven (Chief Scientific Officer) Sale 5,000 27.42 137,110
2016-07-19 Shak Steven (Chief Scientific Officer) Option Ex 5,000 18.89 94,450
2016-07-06 Cole G Bradley (COO) Sale 5,000 26.64 133,225
2016-07-06 Cole G Bradley (COO) Option Ex 5,000 18.89 94,450
2016-06-21 Shak Steven (Chief Scientific Officer) Sale 5,000 26.21 131,045
2016-06-21 Shak Steven (Chief Scientific Officer) Option Ex 5,000 18.89 94,450
2016-06-09 Cole G Bradley (COO) Sale 5,000 26.91 134,545
2016-06-09 Cole G Bradley (COO) Option Ex 5,000 18.89 94,450
2016-06-06 Vaughn James J (Chief Commercial Officer) Sale 1,997 28.00 55,916
2016-06-06 Vaughn James J (Chief Commercial Officer) Option Ex 1,997 18.89 37,723
2016-05-17 14159, L.p. (Director) Option Ex 49,500 10.73 531,135
2016-05-16 Cole G Bradley (COO) Sale 5,000 27.60 137,995
2016-05-16 Cole G Bradley (COO) Option Ex 5,000 18.89 94,450
2016-05-10 Febbo Phillip G. (Chief Medical Officer) Sale 6,324 27.66 174,915
2016-05-09 Vaughn James J (Chief Commercial Officer) Sale 2,000 28.00 56,000
2016-05-09 Vaughn James J (Chief Commercial Officer) Option Ex 2,000 18.89 37,780
2016-05-04 Shak Steven (Chief Scientific Officer) Sale 10,000 25.43 254,300
2016-05-04 Shak Steven (Chief Scientific Officer) Option Ex 10,000 18.89 188,900
2016-01-13 Livingston Randall S (Director) Sale 1,250 32.14 40,175
2016-01-13 Livingston Randall S (Director) Option Ex 1,250 10.73 13,412
2016-01-12 Cole G Bradley (COO) Sale 4,000 31.25 125,004
2016-01-12 Cole G Bradley (COO) Option Ex 4,000 18.89 75,560
2016-01-12 Popovits Kimberly J (President and CEO) Sale 5,000 30.34 151,680
2016-01-12 Popovits Kimberly J (President and CEO) Option Ex 5,000 18.89 94,450
2016-01-07 Vaughn James J (Chief Commercial Officer) Sale 2,000 33.63 67,266
2016-01-07 Vaughn James J (Chief Commercial Officer) Option Ex 2,000 18.89 37,780
2015-12-15 Popovits Kimberly J (President and CEO) Sale 5,000 30.00 150,000
2015-12-15 Popovits Kimberly J (President and CEO) Option Ex 5,000 18.89 94,450
2015-12-08 Cole G Bradley (COO) Sale 4,000 29.26 117,032
2015-12-08 Cole G Bradley (COO) Option Ex 4,000 18.89 75,560
2015-12-07 Vaughn James J (Chief Commercial Officer) Sale 2,000 29.33 58,668
2015-12-07 Vaughn James J (Chief Commercial Officer) Option Ex 2,000 18.89 37,780
2015-12-07 Leber Laura (Chief Communication Officer) Sale 4,200 29.33 123,202
2015-12-07 Leber Laura (Chief Communication Officer) Option Ex 4,200 10.15 42,630
2015-11-10 Cole G Bradley (COO) Sale 4,000 26.03 104,128
2015-11-10 Cole G Bradley (COO) Option Ex 4,000 18.89 75,560
2015-09-09 Cole G Bradley (COO) Sale 3,664 25.40 93,058
2015-09-09 Cole G Bradley (COO) Option Ex 3,664 9.39 34,404
2015-09-08 Cole G Bradley (COO) Sale 6,000 25.32 151,932
2015-09-08 Cole G Bradley (COO) Option Ex 6,000 9.39 56,340
2015-07-07 Cole G Bradley (COO) Sale 4,000 27.53 110,112
2015-07-07 Cole G Bradley (COO) Option Ex 4,000 9.39 37,560
2015-06-09 Cole G Bradley (COO) Sale 4,000 26.24 104,964
2015-06-09 Cole G Bradley (COO) Option Ex 4,000 9.39 37,560
2015-05-12 Cole G Bradley (COO) Sale 4,000 27.56 110,240
2015-05-12 Cole G Bradley (COO) Option Ex 4,000 9.39 37,560
2015-04-13 Popovits Kimberly J (President and CEO) Sale 3,000 31.28 93,840
2015-04-13 Popovits Kimberly J (President and CEO) Option Ex 3,000 18.89 56,670
2015-04-07 Cole G Bradley (COO) Sale 4,000 30.44 121,748
2015-04-07 Cole G Bradley (COO) Option Ex 4,000 9.39 37,560
2015-03-12 Popovits Kimberly J (President and CEO) Sale 3,000 31.91 95,718
2015-03-12 Popovits Kimberly J (President and CEO) Option Ex 3,000 18.89 56,670
2015-03-10 Cole G Bradley (COO) Sale 4,000 32.14 128,556
2015-03-10 Cole G Bradley (COO) Option Ex 4,000 9.39 37,560
2015-02-12 Popovits Kimberly J (President and CEO) Sale 3,000 29.86 89,565
2015-02-12 Popovits Kimberly J (President and CEO) Option Ex 3,000 18.89 56,670
2015-02-10 Cole G Bradley (COO) Sale 4,000 31.37 125,468
2015-02-10 Cole G Bradley (COO) Option Ex 4,000 9.39 37,560
2015-02-02 Livingston Randall S (Director) Sale 1,000 31.93 31,931
2015-02-02 Livingston Randall S (Director) Option Ex 1,000 10.73 10,730
2015-01-12 Popovits Kimberly J (President and CEO) Sale 3,000 33.46 100,386
2015-01-12 Popovits Kimberly J (President and CEO) Option Ex 3,000 18.89 56,670
2014-12-11 Popovits Kimberly J (President and CEO) Sale 3,000 33.08 99,231
2014-12-11 Popovits Kimberly J (President and CEO) Option Ex 3,000 18.89 56,670
2014-12-08 Cole G Bradley (COO) Sale 4,336 32.52 141,002
2014-12-08 Cole G Bradley (COO) Option Ex 4,336 9.39 40,715
2014-11-12 Popovits Kimberly J (President and CEO) Sale 4,300 34.83 149,764
2014-11-12 Popovits Kimberly J (President and CEO) Option Ex 4,300 18.89 81,227
2014-11-10 Cole G Bradley (COO) Sale 4,000 35.35 141,388
2014-11-10 Cole G Bradley (COO) Option Ex 4,000 9.39 37,560
2014-11-03 Livingston Randall S (Director) Sale 3,000 36.24 108,720
2014-11-03 Livingston Randall S (Director) Option Ex 3,000 10.73 32,190
2014-10-13 Popovits Kimberly J (President and CEO) Sale 3,000 30.77 92,325
2014-10-13 Popovits Kimberly J (President and CEO) Option Ex 3,000 18.89 56,670
2014-10-08 Cole G Bradley (COO) Sale 4,000 28.77 115,096
2014-10-08 Cole G Bradley (COO) Option Ex 4,000 9.39 37,560
2014-09-11 Popovits Kimberly J (President and CEO) Sale 3,000 29.82 89,445
2014-09-11 Popovits Kimberly J (President and CEO) Option Ex 3,000 14.14 42,420
2014-09-08 Cole G Bradley (COO) Sale 4,700 30.09 141,427
2014-09-08 Cole G Bradley (COO) Option Ex 4,700 6.13 28,834
2014-08-14 Shak Steven (EVP of R&D) Sale 6,348 27.49 174,500
2014-08-14 Shak Steven (EVP of R&D) Option Ex 6,348 2.88 18,282
2014-08-13 Shak Steven (EVP of R&D) Sale 7,000 27.25 190,729
2014-08-13 Shak Steven (EVP of R&D) Option Ex 7,000 2.88 20,160
2014-08-12 Popovits Kimberly J (President and CEO) Sale 3,000 26.07 78,201
2014-08-12 Popovits Kimberly J (President and CEO) Option Ex 3,000 9.39 28,170
2014-07-14 Popovits Kimberly J (President and CEO) Sale 3,000 26.59 79,776
2014-07-14 Popovits Kimberly J (President and CEO) Option Ex 3,000 9.39 28,170
2014-07-08 Cole G Bradley (COO) Sale 2,300 27.05 62,208
2014-07-08 Cole G Bradley (COO) Option Ex 2,300 2.88 6,624
2014-07-01 Shak Steven (EVP of R&D) Sale 7,000 27.00 188,972
2014-07-01 Shak Steven (EVP of R&D) Option Ex 7,000 2.88 20,160
2014-06-12 Shak Steven (EVP of R&D) Sale 7,000 26.68 186,739
2014-06-12 Shak Steven (EVP of R&D) Option Ex 7,000 2.88 20,160
2014-06-12 Popovits Kimberly J (President and CEO) Sale 3,000 26.10 78,294
2014-06-12 Popovits Kimberly J (President and CEO) Option Ex 3,000 9.39 28,170
2014-06-10 Schorno Dean L (CFO) Sale 4,000 27.62 110,488
2014-06-10 Schorno Dean L (CFO) Option Ex 4,000 18.04 72,140
2014-06-09 Cole G Bradley (COO) Sale 2,337 27.29 63,767
2014-06-09 Cole G Bradley (COO) Option Ex 2,337 2.88 6,730
2014-05-12 Popovits Kimberly J (President and CEO) Sale 3,000 26.78 80,331
2014-05-12 Popovits Kimberly J (President and CEO) Option Ex 3,000 9.39 28,170
2014-05-09 Schorno Dean L (CFO) Sale 4,000 25.09 100,360
2014-05-09 Schorno Dean L (CFO) Option Ex 4,000 18.04 72,140
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of GHDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genomic Health Inc (symbol GHDX, CIK number 1131324) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.